ALMIRALL SA (ALMRY) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 4 5 sessions, February 19, 2025 to March 2, 2026
- Largest daily move
- +12% close of March 2, 2026
- 1-year change
- +47.6% closing prices, February 19, 2025 to March 2, 2026
Company Description
ALMIRALL SA (OTC: ALMRY) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $3.2B.
ALMRY has gained 47.6% over the past year. The last closing price was $14.07.
This page collects what Stock Titan holds for ALMRY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ALMIRALL SA (ALMRY) closed at $14.07 on March 2, 2026. Over the past 12 months, the price has gained 47.6%.
ALMRY Metrics & Rankings
Price returns through March 2, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
ALMIRALL SA has 7 recent news articles. Key topics include conferences, clinical trial. View all ALMRY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ALMRY Company Profile & Sector Positioning
ALMIRALL SA (ALMRY) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing ALMRY often look at related companies in the same sector, including SOFGEN PHARMA S.A (PROCF), ALMIRALL SA (LBTSF), HYPERA SA (HYPMY), SUMITOMO PHARMA CO (SMDPY), and HIKMA PHARMS PLC (HKMPY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ALMRY's relative position within its industry.